Recent decisions by federal health agencies have been highly dubious — so that’s what makes the Food and Drug Administration’s approval of another generic version of the abortion pill mifepristone so noteworthy. In a good way: this preserves access to the pill — and to birth-control choice — despite pro-life pressure to the contrary.

The FDA did what it’s supposed to do: make apolitical decisions, based on scientific evidence. By law, a drug application must be approved if it demonstrates that the generic drug is identical to the brand-name drug. The FDA approved mifepristone 25 years ago, and in 2019 OK’d the first generic version.

See Full Page